Search results
Moderna Inc (MRNA) Q1 2024 Earnings: Significant Revenue Decline
Guru Focus· 5 days agoOn May 2, 2024, Moderna Inc (MRNA, Financial) released its 8-K filing, disclosing a challenging first quarter with total revenues of $167 million, a stark decline from $1.9 ...
Moderna Reports First Quarter 2024 Financial Results and Provides Business Updates
Digital Journal· 5 days agoReports first quarter revenues of $167 million, GAAP net loss of $1.2 billion and GAAP diluted EPS of $(3.07)Prepares for launches of RSV vaccine and Spikevax® 2024-2025 formula ...
News Highlights: Top Company News of the Day - Thursday at 11 AM ET
Morningstar· 5 days agoAn activist investor had called for McCarthy's ouster and for the fitness-equipment maker to sell itself. Shares ticked up premarket as the company says it plans to return ...
IMF chief calls U.S. debt load 'mind boggling,' Musk warns about AI at Milken conference
LA Times via Yahoo Finance· 18 hours agoLightcap said that 92% of Fortune 500 companies are using the company's ChatGPT enterprise product....
Mission Wealth Management LP Acquires New Holdings in Moderna, Inc. (NASDAQ:MRNA)
ETF DAILY NEWS· 2 days agoThe fund bought 2,063 shares of the company’s stock, valued at approximately $205,000. Allworth Financial LP increased its position in Moderna by 6.5% in ...
Safe and Effective? The New York Times Revisits the COVID Jab. - The American Spectator | USA News...
American Spectator· 3 days agoIt has taken three years, but the New York Times has finally admitted that maybe, just maybe, there are some serious side effects to COVID vaccines. AstraZeneca ...
3 Biotech Stocks with Blockbuster Drug Pipelines: April Edition
InvestorPlace· 7 days agoBiotech stocks offer the opportunity to invest in life-saving treatments and drugs. If you want to...
TIME100 Health: Katalin Kariko and Drew Weissman
Time via Yahoo News· 5 days agoIn under a year, both Pfizer-BioNTech and Moderna developed mRNA-based COVID-19 vaccines based on Kariko and Weissman ...
Royal Bank of Canada Increases Moderna (NASDAQ:MRNA) Price Target to $135.00
ETF DAILY NEWS· 2 days agoRoyal Bank of Canada’s target price would indicate a potential upside of 8.00% from the stock’s previous close. Canaccord Genuity Group boosted their price ...
TIME100 Health: Katalin Kariko and Drew Weissman
Time Magazine· 5 days agoDr. Drew Weissman was working on developing an HIV vaccine, and Katalin Kariko was struggling to keep her lab open and convince her superiors that her...